How to Take Turmeric for Inflammation: Joint Pain by the Numbers
In this article
- Is it worth taking turmeric for joint pain?
- Does turmeric help every type of arthritis?
- Can turmeric replace my NSAID or prednisolone?
- How much turmeric should you take daily for joint pain?
- Which type of turmeric is most effective for arthritis pain?
- When should you judge whether turmeric has helped your knee?
- Is curcumin anti-inflammatory, and what does that mean?
- What should you check before you start?
- What we don't know
- Frequently asked questions
For joint pain, the evidence is for a standardised extract at 500 to 1,500 mg of curcuminoids a day, with meals, for 8 to 12 weeks, and it is evidence for knee osteoarthritis. Across 23 trials and 2,175 people, curcuminoid extracts lowered knee pain by about 1.6 points on a 10-point scale against placebo and roughly halved the odds of side effects compared with anti-inflammatory painkillers, in trials that were short, mostly small and mostly Asian.1, 2 In three head-to-head trials they relieved pain about as well as ibuprofen or diclofenac over 4 to 6 weeks with fewer stomach complaints, one review found them less effective than ibuprofen, and an Australian placebo trial, part supplier-funded, found a modest 9 mm change and nothing on MRI.3, 4, 5, 6, 2 Turmeric has no authorised health claim in Great Britain.7 This is the arthritis spoke of the Wellgard turmeric guide.
Sources checked on 1 November 2026.
Is it worth taking turmeric for joint pain?
Turmeric is the "golden herb" of the search box, and for a knee with osteoarthritis a fair trial is reasonable; for anything else the evidence is thin. Eleven meta-analyses agree: pain and function improved more on curcuminoid extracts than on placebo, with less need for rescue painkillers.1, 2, 8, 9 The size: 1.6 to 2 points on a 10-point scale pooled, 9 mm on a 100 mm line in the 70-person Tasmanian trial, and no change in swelling or cartilage on MRI at 12 weeks.1, 6, 8 The NHS calls exercise one of the most important treatments for osteoarthritis, with weight loss where needed.10 What is the best joint supplement compares curcumin with glucosamine, chondroitin and collagen by trial dose and result; how can I naturally lubricate my joints explains why movement comes first.
Does turmeric help every type of arthritis?
No.
- Knee osteoarthritis. Nearly all the trials, and the numbers above.2
- Rheumatoid arthritis. Six small trials of 539 people found lower disease-activity scores (DAS28 down 1.2), a lower ESR and fewer swollen and tender joints: evidence for a rheumatology team to weigh, never a reason to change medicine.11
- Polymyalgia rheumatica and giant cell arteritis. No trials. Prednisolone is the main treatment for polymyalgia, and giant cell arteritis needs immediate medical attention because it can cause stroke or blindness.12
- Fibromyalgia and menopausal aches. No trial evidence; menopause joint pain covers what has some.
Can turmeric replace my NSAID or prednisolone?
No. The NSAID comparison is narrower than it sounds: in a Thai trial of 367 people, a turmeric extract at 1,500 mg a day matched ibuprofen on pain and function over four weeks with fewer stomach complaints; in an earlier trial of 107 people it matched ibuprofen over six weeks except on stairs; and in an open-label Indian trial of 139 people, curcumin at 500 mg three times a day matched diclofenac at days 14 and 28 with side effects in 13% against 38%.3, 4, 5 Those are short knee results, one review found curcuminoids less effective than ibuprofen, and none tested stopping a medicine someone needs.2 Prednisolone does a job in polymyalgia and giant cell arteritis that turmeric has never been tested for, and its dose is reduced gradually under medical supervision, never swapped for a supplement.12 Turmeric can sit alongside what your GP prescribes, with the pharmacist told; it does not replace it.
How much turmeric should you take daily for joint pain?
The positive trials used 500 to 1,500 mg of curcuminoids a day as a standardised extract, usually in two or three doses with meals, and a pooled analysis of 11 trials and 1,258 people found 1,000 mg or more relieved pain no better than less.1, 8, 13 Mind the unit: a 500 mg powder capsule holds about 16 mg of curcumin, a 500 mg extract at 95% about 475 mg of curcuminoids, a 3 to 4 g teaspoon roughly 95 to 125 mg of curcumin.14 How much turmeric a day explains the label units and the food-colour intake figure.
Which type of turmeric is most effective for arthritis pain?
The trials tested extracts, not the spice jar; an extract with its curcuminoid content on the label is what the evidence is about. The 2025 network analysis of 17 trials found every preparation, plain curcuminoid extract and absorption-enhanced alike, reduced knee pain against placebo, at low certainty.15 Black pepper extract raised curcumin's blood levels for up to an hour in the 1998 study; in laboratory tests piperine also blocks the liver enzyme CYP3A4 and the transporter P-glycoprotein that many medicines rely on, so a pepper product deserves a word with your pharmacist if you take regular medicines.16, 17 Forms differ in dose per serving; read the curcuminoid figure. How to take turmeric covers food, fat, timing and the label.
When should you judge whether turmeric has helped your knee?
At weeks 8 to 12, after a first change at two to four weeks: matching scores at day 14 in the diclofenac comparison, at four weeks against ibuprofen, and at the end of the 12-week placebo trial.3, 5, 6 Score your worst joint for a week before starting, change nothing else, take a trial dose with meals, score at weeks 4, 8 and 12, and decide then. How long does turmeric take to work has the method and what stopping can and cannot show.
Is curcumin anti-inflammatory, and what does that mean?
Measurably, in the blood. Across 66 trials in adults, curcumin lowered C-reactive protein by about 0.6 mg/L and the cytokines IL-6 and TNF-alpha by small amounts; a review limited to chronic inflammatory diseases found no significant change.18, 19 A marker is not a symptom, and turmeric has no authorised health claim in Great Britain; the one curcumin joint claim assessed, "contributes to the normal functioning of joints", was refused in 2018 and is listed in the GB register as non-authorised.7
What should you check before you start?
Five checks, in full on who should not take turmeric and what are the side effects of turmeric; is curcumin safe to take daily covers long-term use. Liver: rare, idiosyncratic liver injury has been reported with turmeric supplements, typically one to four months in, with high-dose, high-absorption products in an Italian series, and resolving on stopping in the case series; the UK Committee on Toxicity found reasonable evidence for the link in December 2024.20, 21, 22 Dark urine, pale stools, yellow skin or eyes, nausea or abdominal pain mean stop and see a GP that day; anyone on methotrexate or another liver-processed medicine should ask for liver tests first. Gallstones: curcumin contracts the gallbladder at doses as small as 20 mg; NHS Wales's medicines advice service advises avoiding turmeric with gallstones or bile-duct disease.23, 24 Anticoagulants and antiplatelets: laboratory platelet effects, no INR change in an uncontrolled ten-day human study; tell your clinic, and stop medicinal turmeric at least two weeks before planned surgery.25, 24 Pregnancy and breastfeeding: pregnancy studies are in animals only, so supplement doses have no human safety data; the spice in food is normal.26 Iron tablets: one case of anaemia at about 3.2 g of extract a day; tell your GP.27
What we don't know
- Joints other than the knee: nearly all the trials are in knee osteoarthritis.2
- Long-term effect: the trials ran weeks to months, and no supplement in a 2018 review showed clinically important pain effects at long-term follow-up.28
- Which preparation is best: the 2025 network analysis rated its evidence low certainty.15
- How sure the pooled results are: a 2025 overview of the seven systematic reviews of curcumin for knee osteoarthritis rated 37 of their 48 outcomes extremely low quality, with a high risk of bias in four reviews and the same trials counted across them, so the pain benefit is consistent in direction and not yet certain in size (no commercial conflicts declared; funding not stated on PubMed).30
Frequently asked questions
Is black pepper good for arthritis?
No trial has tested it. Piperine raised curcumin's blood levels for up to an hour in the 1998 study and alters how the liver clears some medicines in laboratory tests; that is all.16, 17
Which is better for inflammation, tart cherry or turmeric?
No trial has compared them. Tart cherry's inflammation data come from week-long exercise trials, set out on what tart cherry is good for; turmeric's come from the weeks-long knee trials above.
Which is better for inflammation, ginger or turmeric?
Neither has been tested against the other. A 2022 meta-analysis found both reduced knee osteoarthritis pain against placebo, curcumin in 12 trials and ginger in 3; curcumin has far more trials.29 A 2018 review of 69 trials listed turmeric extract and curcumin, not ginger, among supplements with large short-term effects on pain, at very low certainty overall.28
How much turmeric do I take for arthritis pain?
What the trials used: 500 to 1,500 mg of curcuminoids a day as a standardised extract; 1,000 mg or more did not help more.3, 13
What can I take instead of turmeric, or what is better than it?
Glucosamine sulphate, chondroitin, collagen peptides and omega-3 (in rheumatoid arthritis) have their own trials, compared on the joint supplement page; a 2022 review of 12 trials found curcumin beat placebo but not active treatment (NSAIDs, chondroitin or paracetamol) on knee pain and function.29 Boswellia is the pairing people ask about. In a 12-week trial of 201 people aged 40 to 70 with osteoarthritis, run on a grant from the capsule maker, which also supplied the capsules, a curcuminoid-plus-boswellic-acid capsule three times a day beat placebo on the WOMAC pain index while the curcuminoid capsule alone did so only on physical performance tests; two Australian placebo-controlled trials of multi-ingredient combinations that included both herbs, 106 people with hand osteoarthritis and 84 with knee osteoarthritis over 12 weeks, found no significant difference from placebo (the hand trial lists research support from a source other than the US government on PubMed, funder not named; funding for the knee trial is not stated on PubMed); and we found no trial that tested turmeric alone, boswellia alone and the two together at matched doses, so "better together" is untested. Boswellia on its own is on what is the best joint supplement.31, 32, 33
Sources
- Zhao J, et al. Efficacy and safety of curcumin therapy for knee osteoarthritis: a Bayesian network meta-analysis. Journal of Ethnopharmacology, 2024. Network meta-analysis, 23 trials, 2,175 people; no competing interests declared, funding not stated on PubMed. PubMed 38036015.
- Onakpoya IJ, et al. Effectiveness of curcuminoids in the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomized clinical trials. International Journal of Rheumatic Diseases, 2017. Meta-analysis, 7 trials, 797 people, all in Asia; funding not stated on PubMed. PubMed 28470851.
- Kuptniratsaikul V, et al. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clinical Interventions in Aging, 2014. Randomised non-inferiority trial, 367 people, 4 weeks; funding not stated on PubMed. PubMed 24672232.
- Kuptniratsaikul V, et al. Efficacy and safety of Curcuma domestica extracts in patients with knee osteoarthritis. Journal of Alternative and Complementary Medicine, 2009. Randomised controlled trial against ibuprofen, 107 people, 6 weeks; funding not stated on PubMed. PubMed 19678780.
- Shep D, et al. Safety and efficacy of curcumin versus diclofenac in knee osteoarthritis: a randomized open-label parallel-arm study. Trials, 2019. Randomised open-label trial, 139 people, 28 days; no competing interests declared. PubMed 30975196.
- Wang Z, et al. Effectiveness of Curcuma longa extract for the treatment of symptoms and effusion-synovitis of knee osteoarthritis: a randomized trial. Annals of Internal Medicine, 2020. Randomised placebo-controlled trial, 70 people, 12 weeks; funded by the University of Tasmania and the extract's manufacturer. PubMed 32926799.
- Department of Health and Social Care. Great Britain nutrition and health claims (NHC) register. Official register. Register spreadsheet, 19 May 2026 edition, Art. 13(5) entry for curcumin, Commission Regulation (EU) 2018/1556. gov.uk.
- Daily JW, Yang M, Park S. Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: a systematic review and meta-analysis of randomized clinical trials. Journal of Medicinal Food, 2016. Meta-analysis, 8 trials; funding not stated on PubMed. PubMed 27533649.
- Bideshki MV, et al. The efficacy of curcumin in relieving osteoarthritis: a meta-analysis of meta-analyses. Phytotherapy Research, 2024. Umbrella review, 11 meta-analyses; university research funding. PubMed 38576215.
- NHS. Osteoarthritis: treatment and support. Page last reviewed 20 March 2023 (review overdue). nhs.uk/conditions/osteoarthritis/treatment.
- Kou H, et al. Effect of curcumin on rheumatoid arthritis: a systematic review and meta-analysis. Frontiers in Immunology, 2023. Meta-analysis, 6 trials, 539 people; no commercial conflicts declared. PubMed 37325651.
- NHS. Polymyalgia rheumatica. Page last reviewed 23 April 2023 (review overdue). nhs.uk/conditions/polymyalgia-rheumatica.
- Hsiao AF, et al. The efficacy of high- and low-dose curcumin in knee osteoarthritis: a systematic review and meta-analysis. Complementary Therapies in Medicine, 2021. Meta-analysis, 11 trials, 1,258 people; funding not stated on PubMed. PubMed 34537344.
- Tayyem RF, Heath DD, Al-Delaimy WK, Rock CL. Curcumin content of turmeric and curry powders. Nutrition and Cancer, 2006. Laboratory analysis of 28 spice products; funding not stated on PubMed. PubMed 17044766.
- Wai HS, et al. Effect of turmeric products on knee osteoarthritis: a systematic review and network meta-analysis. BMC Complementary Medicine and Therapies, 2025. Network meta-analysis, 17 trials; no competing interests declared. PubMed 40731001.
- Shoba G, et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica, 1998. Pharmacokinetic study in rats and healthy volunteers, single doses; funding not stated on PubMed. PubMed 9619120.
- Bhardwaj RK, et al. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. Journal of Pharmacology and Experimental Therapeutics, 2002. Laboratory study in human gut cells and liver microsomes; funding not stated on PubMed. PubMed 12130727.
- Dehzad MJ, et al. Antioxidant and anti-inflammatory effects of curcumin/turmeric supplementation in adults: a GRADE-assessed systematic review and dose-response meta-analysis. Cytokine, 2023. Meta-analysis, 66 randomised trials; no competing interests declared, funding not stated on PubMed. PubMed 36804260.
- White CM, et al. Oral turmeric/curcumin effects on inflammatory markers in chronic inflammatory diseases: a systematic review and meta-analysis. Pharmacological Research, 2019. Meta-analysis, 19 trials, 1,344 people; funding not stated on PubMed. PubMed 31121255.
- Halegoua-DeMarzio D, et al. Liver injury associated with turmeric, a growing problem: ten cases from the Drug-Induced Liver Injury Network. American Journal of Medicine, 2023. Case series, 10 people, US network cases 2004 to 2022; US National Institutes of Health funding. PubMed 36252717.
- Lombardi N, et al. Acute liver injury following turmeric use in Tuscany: an analysis of the Italian Phytovigilance database and systematic review of case reports. British Journal of Clinical Pharmacology, 2021. Case analysis, 7 people, and systematic review of 23 published cases; funding not stated on PubMed. PubMed 32656820.
- Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment. Statement on the potential risk to human health of turmeric and curcumin supplements (COT/2024/07), summary and conclusions, December 2024. Expert committee statement, including a 2021 survey of 15 UK supplements; read in the UK Government Web Archive, as the committee's own site has withdrawn the page. webarchive.nationalarchives.gov.uk.
- Rasyid A, et al. Effect of different curcumin dosages on human gall bladder. Asia Pacific Journal of Clinical Nutrition, 2002. Randomised single-blind crossover trial, 12 healthy volunteers, single doses; funding not stated on PubMed. PubMed 12495265.
- Welsh Medicines Advice Service (NHS Wales). Turmeric: potential adverse effects. Professional guidance, published 22 October 2024. wmic.wales.nhs.uk.
- Hu S, et al. Interaction study between antiplatelet agents, anticoagulants, thyroid replacement therapy and a bioavailable formulation of curcumin. European Review for Medical and Pharmacological Sciences, 2018. Uncontrolled before-and-after study in patients on each medicine, 10 to 15 days; funding not stated on PubMed. PubMed 30070343.
- Tossetta G, et al. The multifaced actions of curcumin in pregnancy outcome. Antioxidants, 2021. Narrative review; pregnancy studies in animals only; no conflicts declared. PubMed 33477354.
- Smith TJ, Ashar BH. Iron deficiency anemia due to high-dose turmeric. Cureus, 2019. Case report, 1 person; no competing interests declared. PubMed 30899609.
- Liu X, et al. Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis. British Journal of Sports Medicine, 2018. Meta-analysis, 69 trials of 20 supplements; no competing interests declared. PubMed 29018060.
- Mathieu S, et al. A meta-analysis of the impact of nutritional supplementation on osteoarthritis symptoms. Nutrients, 2022. Meta-analysis, 12 curcumin trials, 1,438 people; no conflicts declared. PubMed 35458170.
- Chen J, et al. A critical review of systematic reviews and meta-analyses of curcumin for knee osteoarthritis. Frontiers in Pharmacology, 2025. Overview of 7 systematic reviews, 48 outcomes graded; no commercial conflicts declared, funding not stated on PubMed. PubMed 41560742.
- Haroyan A, et al. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study. BMC Complementary and Alternative Medicine, 2018. Three-arm randomised placebo-controlled trial, 201 people aged 40 to 70, 12 weeks; grant from the products' maker (a US supplement company named on the PubMed record), which also donated the capsules and states it had no other involvement. PubMed 29316908.
- Liu X, et al. Efficacy and safety of a supplement combination on hand pain among people with symptomatic hand osteoarthritis: the RADIANT study. Osteoarthritis and Cartilage, 2021. Randomised placebo-controlled trial, 106 people, 12 weeks; research support from a source other than the US government listed on PubMed, funder not named. PubMed 33617972.
- Yuan S, et al. Effect of an oral complementary medicine combination for symptomatic knee osteoarthritis: a double-blind, randomized, placebo-controlled trial. Osteoarthritis and Cartilage, 2026. Randomised placebo-controlled trial (ATLAS), 84 people, 12 weeks; funding not stated on PubMed. PubMed 42331134.
Spotted something out of date? Email support@wellgard.co.uk with the page address and the sentence.
General information, not medical advice. Ask your pharmacist or GP before a turmeric supplement if you take regular medicines, have gallstones or a liver condition, or are pregnant or breastfeeding; never stop or change a prescribed medicine on the strength of one.